| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |